-----BEGIN PRIVACY-ENHANCED MESSAGE----- Proc-Type: 2001,MIC-CLEAR Originator-Name: webmaster@www.sec.gov Originator-Key-Asymmetric: MFgwCgYEVQgBAQICAf8DSgAwRwJAW2sNKK9AVtBzYZmr6aGjlWyK3XmZv3dTINen TWSM7vrzLADbmYQaionwg5sDW3P6oaM5D3tdezXMm7z1T+B+twIDAQAB MIC-Info: RSA-MD5,RSA, KJ/O4wX/rX2xwt7RWSdsLsyK3cPr7QWogt0VydHHDE6Ck+6cVj1+59z3VQIrNwJH /JFHHuSc9GHqxSVzPjx0Sw== 0000950159-06-001374.txt : 20061019 0000950159-06-001374.hdr.sgml : 20061019 20061019161132 ACCESSION NUMBER: 0000950159-06-001374 CONFORMED SUBMISSION TYPE: 13F-HR/A PUBLIC DOCUMENT COUNT: 1 CONFORMED PERIOD OF REPORT: 20060630 FILED AS OF DATE: 20061019 DATE AS OF CHANGE: 20061019 EFFECTIVENESS DATE: 20061019 FILER: COMPANY DATA: COMPANY CONFORMED NAME: PERCEPTIVE ADVISORS LLC CENTRAL INDEX KEY: 0001224962 IRS NUMBER: 000000000 STATE OF INCORPORATION: DE FISCAL YEAR END: 1231 FILING VALUES: FORM TYPE: 13F-HR/A SEC ACT: 1934 Act SEC FILE NUMBER: 028-10438 FILM NUMBER: 061153535 BUSINESS ADDRESS: STREET 1: PERCEPTIVE CAPITAL STREET 2: 5437 CONNECTICUT AVENUE NW STE 100 CITY: WASHINGTON STATE: DC ZIP: 20015 BUSINESS PHONE: 2025370029 13F-HR/A 1 perceptive13f.txt UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 Form 13F FORM 13F COVER PAGE Report for the Calendar Year or Quarter Ended: June 30, 2006 Check here if Amendment [X]; Amendment Number: 1 ---------- This Amendment (Check only one.): [ ] is a restatement. [X] adds new holdings entries. Institutional Investment Manager Filing this Report: Name: Perceptive Advisors LLC Address: 7284 West Palmetto Park Road, Suite 301 Boca Raton, FL 33433 Form 13F File Number: 28-10438 The institutional investment manager filing this report and the person by whom it is signed hereby represent that the person signing the report is authorized to submit it, that all information contained herein is true, correct and complete, and that it is understood that all required items, statements, schedules, lists, and tables, are considered integral parts of this form. Persons Signing this Report on Behalf of Reporting Manager: Name: Joseph Edelman Title: Managing Member Phone: 561-391-7770 Signature, Place, and Date of Signing: /s/ Joseph Edelman New York, NY October 19, 2006 - ------------------ ------------ ---------------- [Signature] [City, State] [Date] Report Type (Check only one.): [X] 13F HOLDINGS REPORT. (Check here if all holdings of this reporting manager are reported in this report.) [ ] 13F NOTICE. (Check here if no holdings reported are in this report, and all holdings are reported by other reporting manager(s).) [ ] 13F COMBINATION REPORT. (Check here if a portion of the holdings for this reporting manager is reported in this report and a portion is reported by other reporting manager(s).)
SH/ TITLE SHARES PRN OF VALUE /PRN PUT/ OTHER INVESTMENT VOTING AUTHORITY NAME OF ISSUER CLASS CUSIP (X1000) AMOUNT CALL MANAGERS DISCRETION SOLE SHARED NONE - -------------- ----- ----- ------- ------ ---- -------- ---------- ---- ------ ---- ACADIA PHARMACEUTICALS INC COM 004225108 8073 956469 SH N/A SOLE 40000 ADOLOR CORP COM 00724X102 9226 368900 SH N/A SOLE 368900 ADVANCED MAGNETICS INC COM 00753P103 11686 386700 SH N/A SOLE 80000 ALTUS PHARMACEUTICALS INC COM 02216N105 1909 103500 SH N/A SOLE 85500 AMERISOURCEBERGEN CORP COM 03073E105 419 10000 SH N/A SOLE 10000 ANDRX CORP DEL ANDRX GROUP 034553107 8755 377530 SH N/A SOLE 140000 ANTIGENICS INC DEL COM 037032109 201 95000 CALL N/A SOLE 95000 APPLERA CORP COM CE GEN GRP 038020202 291 22500 SH N/A SOLE 22500 ARRAY BIOPHARMA INC COM 04269X105 1144 133000 SH N/A SOLE 133000 ATHEROGENICS INC COM 047439104 1984 152000 PUT N/A SOLE 152000 ATS MED INC COM 002083103 2705 1131730 SH N/A SOLE 1131730 AUXILIUM PHARMACEUTICALS INC COM 05334D107 26 3381 SH N/A SOLE 3381 AVANIR PHARMACEUTICALS CL A NEW 05348P401 171 25000 SH N/A SOLE 25000 AVI BIOPHARMA INC COM 002346104 15 3900 CALL N/A SOLE 3900 BARD C R INC COM 067383109 8388 114500 SH N/A SOLE 114500 BAUSCH & LOMB INC COM 071707103 932 19000 SH N/A SOLE 19000 BIOCRYST PHARMACEUTICALS COM 09058V103 5210 363550 SH N/A SOLE 363550 BIODELIVERY SCIENCES INTL IN COM 09060J106 341 161639 SH N/A SOLE 161639 BIOENVISION INC COM 09059N100 4723 886067 SH N/A SOLE 886067 BIOGEN IDEC INC COM 09062X103 3520 76002 SH N/A SOLE 76002 CELGENE CORP COM 151020104 20727 437000 SH N/A SOLE 437000 CELL GENESYS INC COM 150921104 238 47500 PUT N/A SOLE 47500 CHARLES RIV LABS INTL INC COM 159864107 1435 39000 SH N/A SOLE 39000 CHELSEA THERAPEUTICS INTL LTD COM 163428105 1161 305580 SH N/A SOLE 305580 CHINA MED TECHNOLOGIES INC SPONSORED ADR 169483104 700 35000 SH N/A SOLE 35000 CONSOLIDATED WATER CO INC ORD G23773107 691 28090 SH N/A SOLE 28090 COTHERIX INC COM 22163T103 654 76000 SH N/A SOLE 76000 CURAGEN CORP NOTE 4.000% 2/1 23126RAE1 4410 6000000 PRN N/A SOLE 6000000 CVS CORP COM 126650100 4022 131000 SH N/A SOLE 131000 CYBERONICS INC COM 23251P102 608 28500 SH N/A SOLE 28500 CYTOGEN CORP COM NEW 232824300 1525 610132 SH N/A SOLE 500000 CYTOKINETICS INC COM 23282W100 613 97500 SH N/A SOLE 50000 DYNAVAX TECHNOLOGIES CORP COM 268158102 128 30875 SH N/A SOLE 30875 ENCYSIVE PHARMACEUTICALS INC COM 29256X107 1350 194750 SH N/A SOLE 194750 ENCYSIVE PHARMACEUTICALS INC COM 29256X107 329 47500 PUT N/A SOLE 47500 ENDO PHARMACEUTICALS HLDGS I COM 29264F205 1517 46000 SH N/A SOLE 46000 ENZON PHARMACEUTICALS INC NOTE 4.500% 7/0 293904AB4 19986 20846000 PRN N/A SOLE 20846000 EXELIXIS INC COM 30161Q104 573 57000 SH N/A SOLE 57000 GENENTECH INC COM NEW 368710406 13010 159050 SH N/A SOLE 159050 GENITOPE CORP COM 37229P507 2101 332500 CALL N/A SOLE 95000 GENOMIC HEALTH INC COM 37244C101 1724 146500 SH N/A SOLE 146500 GENZYME CORP COM 372917104 34830 570523 SH N/A SOLE 570523 HEALTH CARE REIT INC COM 42217K106 1817 52000 SH N/A SOLE 52000 HUMAN GENOME SCIENCES INC COM 444903108 4763 445100 SH N/A SOLE 95000 HUMAN GENOME SCIENCES INC COM 444903108 508 47500 CALL N/A SOLE 47500 ICOS CORP NOTE 2.000% 7/0 449295AB0 1037 1268000 PRN N/A SOLE 1268000 IMCLONE SYS INC COM 45245W109 2917 75500 SH N/A SOLE 66500 INDEVUS PHARMACEUTICALS INC COM 454072109 18063 3302250 SH N/A SOLE 3302250 INDEVUS PHARMACEUTICALS INC NOTE 6.250% 7/1 454072AB5 34406 30280000 PRN N/A SOLE 30280000 INTERMUNE INC COM 45884X103 469 28500 SH N/A SOLE 28500 INVITROGEN CORP COM 46185R100 10736 162500 SH N/A SOLE 20000 ISIS PHARMACEUTICALS INC DEL NOTE 5.500% 5/0 464337AC8 10811 11625000 PRN N/A SOLE 11625000 ISOLAGEN INC COM 46488N103 1612 408105 SH N/A SOLE 408105 LIGAND PHARMACEUTICALS INC CL B 53220K207 18007 2131005 SH N/A SOLE 2131005 LIGAND PHARMACEUTICALS INC CL B 53220K207 442 2302 PUT N/A SOLE 2302 MEDICURE INC COM 58469E101 264 207640 SH N/A SOLE 47500 MEDTRONIC INC COM 585055106 3127 66645 SH N/A SOLE 20000 MERGE TECHNOLOGIES INC COM 589981109 616 50000 SH N/A SOLE 50000 MILLENNIUM PHARMACEUTICALS I COM 599902103 284 28500 SH N/A SOLE 28500 NEOPHARM INC COM 640919106 10449 1960400 CALL N/A SOLE 1960400 NEOPHARM INC COM 640919106 2761 517900 PUT N/A SOLE 285000 NORTHFIELD LABS INC COM 666135108 1216 123000 PUT N/A SOLE 95000 NUCRYST PHARMACEUTICALS CORP COM 67035Q100 245 19000 SH N/A SOLE 19000 OSCIENT PHARMACEUTICALS CORP NOTE 3.500% 4/1 68812RAB1 1984 3000000 PRN N/A SOLE 3000000 PANACOS PHARMACEUTICALS INC COM 69811Q106 105 19000 SH N/A SOLE 19000 PDL BIOPHARMA INC COM 69329Y104 874 47500 SH N/A SOLE 47500 PENWEST PHARMACEUTICALS CO COM 709754105 14872 681264 SH N/A SOLE 681264 PENWEST PHARMACEUTICALS CO COM 709754105 4214 193000 CALL N/A SOLE 25200 PENWEST PHARMACEUTICALS CO COM 709754105 11524 527900 PUT N/A SOLE 435200 PHARMION CORP COM 71715B409 2427 142500 SH N/A SOLE 142500 POZEN INC COM 73941U102 1646 233869 SH N/A SOLE 233869 PROGENICS PHARMACEUTICALS IN COM 743187106 21682 901147 SH N/A SOLE 852997 PROTEIN DESIGN LABS INC NOTE 2.000% 2/1 74369LAF0 2993 3000000 PRN N/A SOLE 3000000 RENOVIS INC COM 759885106 6983 456100 CALL N/A SOLE 361100 REPROS THERAPEUTICS INC COM 76028H100 636 78127 COM N/A SOLE 78127 SCHERING PLOUGH CORP PFD CONV MAND 806605606 906 18000 SH N/A SOLE 18000 SEPRACOR INC COM 817315104 10399 182000 SH N/A SOLE 152750 SEROLOGICALS CORP COM 817523103 9432 300000 SH N/A SOLE 300000 SPDR TR UNIT SER 1 78462F103 7255 57000 SH N/A SOLE 57000 SPECTRUM PHARMACEUTICALS INC COM 84763A108 176 45000 PUT N/A SOLE 45000 TAPESTRY PHARMACEUTICALS INC COM NEW 876031204 63 18660 SH N/A SOLE 18660 TELIK INC COM 87959M109 193 11700 SH N/A SOLE 11700 TELIK INC COM 87959M109 784 47500 PUT N/A SOLE 47500 TELIK INC COM 87959M109 8435 511200 CALL N/A SOLE 166300 UNITED THERAPEUTICS CORP DEL COM 91307C102 8232 142500 SH N/A SOLE 142500 UNITEDHEALTH GROUP INC COM 91324P102 19994 446500 SH N/A SOLE 446500 ZYMOGENETICS INC COM 98985T109 1800 94865 SH N/A SOLE 94865 87 444210
FORM 13F SUMMARY PAGE Report Summary: Number of Other Included Managers: 0 Form 13F Information Table Entry Total: 87 Form 13F Information Table Value Total: $444,210 (thousands) List of Other Included Managers: Provide a numbered list of the name(s) and Form 13F file number(s) of all institutional investment managers with respect to which this report is filed, other than the manager filing this report. [If there are no entries in this list, state "NONE" and omit the column headings and list entries.] NONE -----END PRIVACY-ENHANCED MESSAGE-----